UNSPSC 51144108: Amphetamine hydrochloride

This classification denotes a cns stimulant with the molecular formula C9H13N.CLH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 70DMY940ZG. Most nations, for tariff and trade purposes, schedule amphetamine hydrochloride under HS 29214600. As of Q4 2014, AMPHETAMINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Amphetamine hydrochloride bears US NLM identifiers UMLS ID C2698101 and NCI Concept Code C77844. SMILES: CC(CC1CCCCC1)N.CL.

UNSPSC 51144108 Amphetamine hydrochloride, a Commodity code, shows limited recent state and local procurement activity directly aligned with the code's nominal scope. The three recent opportunities posted under this code involve naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals and OTC products — none of which center on amphetamine hydrochloride procurement. The mismatch suggests either miscoding at the source or that state and local governments are not currently soliciting this controlled substance through standard procurement channels captured in recent opportunity data. If amphetamine hydrochloride procurement does occur, it would likely be restricted to health departments, correctional facilities, or specialized public health agencies handling ADHD treatment programs or opioid-crisis response initiatives, but no such solicitations appear in the recent record.

The geographic spread reflected in the posted opportunities spans Florida (Seminole County), Texas (HHS Commission), and Minnesota (MMCAP cooperative), but these opportunities do not represent genuine demand for amphetamine hydrochloride. The Seminole County IFB (due July 26, 2023) sought naloxone and drug deactivation systems; the Texas HHS RFI (due April 3, 2026) explored direct-to-manufacturer prescription fulfillment models; and the Minnesota MMCAP RFP (due March 26, 2026) covered generic pharmaceuticals and OTC products through authorized wholesalers. None of these represent actionable market signals for amphetamine hydrochloride supply. Business development professionals should treat this code as inactive for near-term pursuit and monitor for future opportunities from state health departments or controlled-substance procurement offices that might represent genuine demand.